Studies on bacterial inclusion bodies

Future Microbiology

Volumn 3, Issue 4, 2008, Pages 423-435

  de Groot, Natalia S ^a   Espargarö, Alba ^a   Morell, Montserrat ^a   Ventura, Salvador ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Amyloid; Chaperone; Escherichia coli; Inclusion bodies; Protein aggregation; Protein folding; Protein production; Protein solubility

Indexed keywords

CELL PROTEIN; POLYPEPTIDE;

BACTERIAL CELL; BIOMEDICINE; BIOTECHNOLOGY; CELL FUNCTION; CELL INCLUSION; DEGENERATIVE DISEASE; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN SYNTHESIS; REVIEW;

BACTERIA; BACTERIAL PROTEINS; INCLUSION BODIES; MODELS, BIOLOGICAL; PROTEIN FOLDING;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PROKARYOTA;

EID: 48649087458     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.3.4.423     Document Type: Review

References (72)

1. Smith A: Protein misfolding. Nature 426, 883 (2003).
2. Dobson CM: Protein folding and misfolding. Nature 426, 884-890 (2003).
3. Rochet JC, Lansbury PT Jr: Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10, 60-68 (2000).
4. Cohen FE, Kelly JW: Therapeutic approaches to protein misfolding diseases. Nature 426, 905-909 (2003).
5. Walsh DM, Selkoe DJ: A β-oligomers: a decade of discovery. J. Neurochem. 101, 1172-1184 (2007).
6. Smith HE: The transcriptional response of Escherichia coli to recombinant protein insolubility. J. Struct. Funct. Genomics 8, 27-35 (2007).
7. Carrio MM, Corchero JL, Villaverde A: Dynamics of in vivo protein aggregation: building inclusion bodies in recombinant bacteria. FEMS Microbiol. Lett. 169, 9-15 (1998).
8. Bowden GA, Paredes AM, Georgiou G: Structure and morphology of protein inclusion bodies in Escherichia coli. Biotechnology (NY) 9. 725-730 (1991).
9. Garcia-Fruitos E, Gonzalez Montalban N, Morell M et al.: Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb. Cell. Fact. 4, 27 (2005).
10. Carrio MM, Cubarsi R, Villaverde A: Fine architecture of bacterial inclusion bodies. FEBS Lett. 471, 7-11 (2000).
11. Carrio M, Gonzalez-Montalban N, Vera A, Villaverde A, Ventura S: Amyloid-like properties of bacterial inclusion bodies. J. Mol. Biol. 347, 1025-1037 (2005).
12. Taylor G, Hoare M, Gray DR, Marston FAO: Size and density of protein inclusion bodies. Biotechnology (NY) 4, 553-557 (1986).
13. Georgiou G, Telford JN, Shuler ML, Wilson DB: Localization of inclusion bodies in Escherichia coli overproducing β-lactamase or alkaline phosphatase. Appl. Environ. Microbiol. 52, 1157-1161 (1986).
14. Bowden GA, Georgiou G: Folding and aggregation of β-lactamase in the periplasmic space of Escherichia coli. J. Biol. Chem. 265, 16760-16766 (1990).
15. Miot M, Betton JM: Protein quality control in the bacterial periplasm. Microb. Cell Fact. 3, 4(2004).
16. Arie JP, Miot M, Sassoon N, Betton JM: Formation of active inclusion bodies in the periplasm of Escherichia coli. Mol. Microbiol. 62, 427-437 (2006).
17. Carrio MM, Villaverde A: Localization of chaperones DnaK and GroEL in bacterial inclusion bodies. J Bacteriol. 187, 3599-3601 (2005).
18. Georgiou G, Valax P: Isolating inclusion bodies from bacteria. Methods Enzymol. 309, 48-58 (1999).
19. Peternel S, Jovsevar S, Bele M. Gabere-Porekar V, Menart V: New properties of inclusion bodies with implications for biotechnology. Biotechnol. Appl. Biochem. 49(Pt 4), 239-246 (2007).
20. Villaverde A, Carrio MM: Protein aggregation in recombinant bacteria: biological role of inclusion bodies, Biotechnol. Lett. 25, 1385-1395 (2003).
21. Carrio MM, Villaverde A: Construction and deconstruction of bacterial inclusion bodies. J. Biotechnol. 96, 3-12 (2002).
22. Clark ED: Protein refolding for industrial processes. Curr. Opin. Biotechnol. 12. 202-207 (2001).
23. Rinas U, Bailey JE: Protein compositional analysis of inclusion bodies produced in recombinant Escherichia coli. Appl. Microbiol. Biotechnol. 37, 609-614 (1992).
24. Carrio MM, Corchero JL, Villaverde A: Proteolytic digestion of bacterial inclusion body proteins during dynamic transition between soluble and insoluble forms. Biochim. Biophys. Acta 1434, 170-176 (1999).
25. Corchero JL, Viaplana E, Benito A, Villaverde A: The position of the heterologous domain can influence the solubility and proteolysis of β-galactosidase fusion proteins in E. coli. J. Biotechnol. 48, 191-200 (1996).
26. Jurgen B, Lin HY, Riemschneider S et al.: Monitoring of genes that respond to overproduction of an insoluble recombinant protein in Escherichia coli glucose-limited fed-batch fermentations. Biotechnol. Bioeng. 70, 217-224 (2000).
27. Rinas U, Hoffmann F, Betiku E, Estape D, Marten S: Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli. J. Biotechnol. 127, 244-257 (2007).
28. Valax P, Georgiou G: Molecular characterization of β-lactamase inclusion bodles produced in Escherichia coli. 1. Composition. Biotechnol. Prog. 9, 539-547 (1993).
29. Hoffmann F, Rinas U: Kinetics of heat-shock response and inclusion body formation during temperature-induced production of basic fibroblast growth factor on high cell density cultures of recombinant Escherichia coli. Biotechnol. Prog. 16, 1000-1007 (2000).
30. Allen SP, Polazzi JO, Gierse JK, Easton AM: Two novel heat shock genes encoding protoins produced in response to heterologous protein expression in Escherichia roli. J. Bacteriol. 174, 6938-6947 (1992).
31. Garcia-Fruitos E, Martinez-Alonso M, Gonzalez-Montalban N, Valli M, Mattanovich D, Villaverde A: Divergent genetic control of protein solubility and conformational quality in Escherichia coli. J. Mol. Biol. 374, 195-205 (2007).
32. London J, Skrzynia C, Goldberg ME: Renaturation of Escherichia coli tryptophanase after exposure to 8 M urea. Evidence for the existence of nucleation centers. Eur. J. Biochem. 47, 409-415 (1974).
33. Speed MA, Wang DI, King J: Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition. Nat. Biotechnol. 14, 1283-1287 (1996).
34. Hart RA, Rinas U, Bailey JE: Protein composition of Vitreoscilla hemoglobin inclusion bodies produced in Escherichia coli. J. Biol. Chem. 265, 12728-12733 (1990).
35. Ben-Zvi AP, Goloubinoff P: Review mechanisms of disaggregation and refolding of stable protein aggregates by molecular chaperones. J. Struct. Biol. 135, 84-93 (2001).
36. Chiti F, Webster P, Taddei N et al.: Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl Acad. Sci. USA 96, 3590-3594 (1999).
37. Harper JD, Lansbury PT Jr: Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66, 395-407 (1997).
38. Fink AL: Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold. Des. 3, R9-R23 (1999).
39. Przybycien TM, Dunn JP, Valax P, Georgiou G: Secondary structure charaterization of β-lactamase inclusion bodies. Protein Eng. 7, 131-136 (1994).
40. Ami D, Natalello A, Gatti Lafranconi P. Lotti M, Doglia SM: Kinetics of inclusion body formation studied in intact cells by FT-IR spectroscopy. FEBS Lett. 579, 3433-3436 (2005).
41. Ami D, Natalello A, Taylor G, Tonon G, Maria Doglia S: Structural analysis of protein inclusion bodies by Fourier transform infrared microspectroscopy. Biochim. Biophys. Acta 1764, 793-799 (2006).
42. Ami D, Bonecchi L, Cali S, Orsini G, Tonon G, Doglia SM: FT-IR study of heterologous protein expression in recombinant Escherichia coli strains. Biochim. Biophys. Acta 1624, 6-10 (2003).
43. Cubarsi R, Carrio MM, Villaverde A: In situ proteolytic digestion of inclusion body polypeptides occurs as a cascade process. Biochem. Biophys. Res. Commun. 282, 436-441. (2001).
44. Cubarsi R, Carrio MM, Villaverde A. A mathematical approach to molecular organization and proteolytic disintegration of bacterial inclusion bodies. Math. Med. Biol. 22, 209-226 (2005).
45. Ventura S, Villaverde A: Protein quality in bacterial inclusion bodies. Trends Biotechnol. 24, 179-185 (2006).
46. Gonzalez-Montalban N, Garcia-Fruitos E, Ventura S, Aris A, Villaverde A: The chaperone DnaK controls the fractioning of functional protein between soluble and insoluble cell fractions in inclusion body-forming cells. Microb. Cell Fact. 5, 26 (2006).
47. Wigley WC, Stidham RD, Smith NM, Hunt JF, Thomas PJ: Protein solubility and folding monitored in vivo by structural complementation of a genetic marker protein. Nat. Biotechnol. 19, 131-136 (2001).
48. de Groot NS, Aviles FX, Vendrell J, Ventura S: Mutagenesis of the central hydrophobic cluster in Aβ42 Alzheimer's peptide. Side-chain properties correlate with aggregation propensities. FEBS J. 273, 658-669 (2006).
49. Sirangelo I, Malmo C, Casillo M, Mezzogiorno A, Papa M, Irace G: Tryptophanyl substitutions in apomyoglobin determine protein aggregation and amyloid like fibril formation at physiological pH. J. Biol. Chem. 277, 45887-45891 (2002).
50. Hammarstrom P, Sekijima Y. White JT et al.: D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis? Biochemistry 42, 6656-6663 (2003).
51. West MW, Wang W, Patterson J, Mancias JD, Beasley JR, Hecht MH: De novo amyloid proteins from designed combinatorial libraries. Proc. Natl Acad. Sci. USA 96, 11211-11216 (1999).
52. Wang W, Hecht MH: Rationally designed mutations convert de novo amyloid-like librils into monomeric β-sheet proteins. Proc. Natl Acad. Sci. USA 99, 2760-2765 (2002).
53. Singh D, Raman B, Ramakrishna T, Rao Ch M: Mixed oligomer formation between human αA-crystallin and its cataract-causing G98R mutant: structural, stability and functional differences. J. Mol. Biol. 373, 1293-1304 (2007).
54. Singh D, Raman B, Ramakrishna T, Rao ChM: The cataract-causing mutation G98R in human αA-crystallin leads to folding defects and loss of chaperone activity. Mol. Vis. 12, 1372-1379 (2006).
55. Bucciantini M, Giannoni E, Chiti F et al.: Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511 (2002).
56. Marianayagam NJ, Sunde M, Matthews JM: The power of two: protein dimerization in biology. Trends Biochem. Sci. 29, 618-625 (2004).
57. Nolting B, Schalike W, Hampel P et al.: Structural determinants of the rate of protein folding. J. Theor. Biol. 223, 299-307 (2003).
58. Idicula-Thomas S, Balaji PV: Correlation between the structural stability and aggregation propensity of proteins. In Silico Biol. 7, 225-237 (2007).
59. Plaxco KW, Simons KT, Baker D: Contact order, transition state placement and the refolding rates of single domain proteins. J. Mol. Biol. 277, 985-994 (1998).
60. Calloni G, Zoffoli S, Stefani M, Dobson CM, Chiti F: Investigating the affects of mutations on protein aggregation in the cell. J. Biol. Chem. 280, 10607-10613 (2005).
61. Qoronfleh MW, Hesterberg LK, Seefeldt MB: Confronting high-throughput protein refolding using high pressure and solution screens. Protein Expr. Purif. 55, 209-224 (2007).
62. de Groot NS, Ventura S: Effect of temperature on protein quality in bacterial inclusion bodies. FEBS Lett. 580, 6471-6476 (2006).
63. de Marco A, Deuerling E, Mogk A, Tomoyasu T, Bukau B: Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli. BMC Biotechnol. 7, 32 (2007).
64. Liu YD, Li JJ, Wang FW, Chen J, Li P, Su ZG: A newly proposed mechanism for arginine-assisted protein refolding: not inhibiting soluble oligomers although promoting a correct structure. Protein Expr. Purif. 51, 235-242 (2007).
65. Diamant S, Rosenthal D, Azem A, Eliahu N, Ben-Zvi AP, Goloubinoff P: Dicarboxylic amino acids and glycine-betaine regulate chaperone-mediated protein-disaggregation under stress. Mol. Microbiol. 49, 401-410 (2003).
66. de Marco A, Vigh L, Diamant S, Goloubinoff P: Native folding of aggregation-prone recombinant proteins in Escherichia coli by osmolytes, plasmid- or benzyl alcohol-overexpressed molecular chaperones. Cell Stress Chaperones 10, 329-339 (2005)
67. Ignatova Z, Gierasch LM: Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectant. Proc. Natl Acad. Sci. USA 103, 13357-13361 (2006).
68. Schultz T, Martinez L, de Marco A: The evaluation of the factors that cause aggregation during recombinant expression in E. coli is simplified by the employment of an aggregation-sensitive reporter. Microb. Cell Fact. 5, 28 (2006).
69. Sanchez de Groot N, Pallares I, Aviles FX, Vendrell J, Ventura S: Prediction of 'hot spots' of aggregation in disease-linked polypeptides. BMC Struct. Biol. 5, 18 (2005).
70. Conchillo-Sole O, de Groot NS, Aviles FX, Vendrell J, Daura X, Ventura S: AGGRESCAN: a server for the prediction and evaluation of 'hot spots' of aggregation in polypeptides. BMC Bioinformatics 8, 65 (2007).
71. Idicula-Thomas S, Kulkarni AJ, Kulkarni BD, Jayaraman VK, Balaji PV: A support vector machine-based method for predicting the propensity of a protein to be soluble or to form inclusion body on overexpression in Escherichia coli. Bioinformatics 22, 278-284 (2006).
72. Smialowski P, Martin-Galiano AJ, Mikolajka A, Girschick T, Holak TA, Frishman D: Protein solubility: sequence-based prediction and experimental verification. Bioinformatics 23, 2536-2542 (2007).